Literature DB >> 10353876

Review: infectious diseases and coagulation disorders.

E C van Gorp1, C Suharti, H ten Cate, W M Dolmans, J W van der Meer, J W ten Cate, D P Brandjes.   

Abstract

Infection, both bacterial and nonbacterial, may be associated with coagulation disorders, resulting in disseminated intravascular coagulation and multiorgan failure. In the last few decades a series of in vivo and in vitro studies has provided more insight into the pathogenetic mechanisms and the role of cytokines in these processes. Because of the growing interest in this field, the complexity of the subject, and the fact that many physicians must deal with a variety of infections, current data are reviewed on the association between infectious diseases and the coagulation system. Novel therapeutic intervention strategies that will probably become available in the near future are mentioned, along with those of special interest for infectious disorders for which only supportive care can be given.

Entities:  

Mesh:

Year:  1999        PMID: 10353876     DOI: 10.1086/314829

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  55 in total

Review 1.  Influenza and cardiovascular disease: is there a causal relationship?

Authors:  Mohammad Madjid; Ibrahim Aboshady; Imran Awan; Silvio Litovsky; S Ward Casscells
Journal:  Tex Heart Inst J       Date:  2004

2.  Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.

Authors:  Jacqueline Neuhaus; David R Jacobs; Jason V Baker; Alexandra Calmy; Daniel Duprez; Alberto La Rosa; Lewis H Kuller; Sarah L Pett; Matti Ristola; Michael J Ross; Michael G Shlipak; Russell Tracy; James D Neaton
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

3.  Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.

Authors:  P Onguru; S Dagdas; H Bodur; M Yilmaz; E Akinci; S Eren; G Ozet
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Impact of the Pla protease substrate α2-antiplasmin on the progression of primary pneumonic plague.

Authors:  Justin L Eddy; Jay A Schroeder; Daniel L Zimbler; Lauren E Bellows; Wyndham W Lathem
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

5.  Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.

Authors:  P Koraka; C Suharti; T E Setiati; A T Mairuhu; E Van Gorp; C E Hack; M Juffrie; J Sutaryo; G M Van Der Meer; J Groen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 6.  COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment.

Authors:  Xiaojing Chen; Chengyuan Yu; Haijiao Jing; Chunxu Wang; Xinyi Zhao; Jinming Zhang; Shuoqi Zhang; Huan Liu; Rujuan Xie; Jialan Shi
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

7.  Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C.

Authors:  Philipp Blüm; Joachim Pircher; Monika Merkle; Thomas Czermak; Andrea Ribeiro; Hanna Mannell; Florian Krötz; Alexander Hennrich; Michael Spannagl; Simone Köppel; Erik Gaitzsch; Markus Wörnle
Journal:  Cell Mol Immunol       Date:  2016-04-18       Impact factor: 11.530

8.  Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.

Authors:  Nicola Semeraro; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

Review 9.  Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens.

Authors:  Amy E Bryant
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 10.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.